Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
DGQuest Diagnostics Incorporated logo

Quest Diagnostics Incorporated (DGX)

New York Stock Exchange · Currency in USD
$241.89 ▼ -1.39 (-0.57%)
At close: Oct 23, 4:02 PM ET. Market closed.
$241.89 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:31 PM ET

Summary

Previous Close
$243.28
Open
$241.13
Day's Range
$239.63 – $244.30
52 Week Range
$171.18 – $248.84
Volume
933,364
Avg. Volume
1,022,441
Market Cap
$26.70B
Beta (5Y Monthly)
0.54
PE Ratio (TTM)
23.76
EPS (TTM)
$10.26
Earnings Date
Feb 9, 2027
Forward Dividend & Yield
$3.44 (1.42%)
Ex-Dividend Date
Oct 6, 2026
1y Target Est
$256.17

Profile: Quest Diagnostics Incorporated

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
51,500
CEO
James E. Davis

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients.

Earnings

Next report: Tue, Feb 9, 2027
EPS estimate $2.68 · Revenue est. $3.04B
DateEst.Actual
Oct 22, 2026$2.87$3.00Beat
Jul 23, 2026$2.82$3.12Beat
Apr 21, 2026$2.37$2.50Beat
Feb 10, 2026$2.36$2.42Beat
Oct 21, 2025$2.50$2.60Beat
Jul 22, 2025$2.57$2.62Beat

Analyst view

Consensus price target
$256.17 ▲ +5.9%
Range $245.00 – $262.00
Rating: Hold
Buy 38% · Hold 53% · Sell 9%

Get free alerts on DGX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.